Pharmaceutical Sciences for the Future of Medicines · Sciences Fair and Exhibition. This event for...

Initiated and organised by:The European Federation for Pharmaceutical Sciences (EUFEPS),several member societies and other proactive scientific organisations

www.pharmscifair.org

Second Announcement

Plenary Sessions & 4 Parallel Programme Days

& Young Scientists Meeting

Pharmaceutical Sciences for the Future of Medicines

June 13-17, 2011, Prague, Czech Republic - the Place where Pharmaceutical Scientists meet

www.pharmscifair.com

Bronze

Contents

Words of Welcome ................................................3

PharmSciFair Organising Committee

and Organisers ......................................................3

Call for Abstracts ...................................................4

Scientific Programme ...................................... 5-13

Young Scientist Meeting .................................... 6-7

Registration, Accommodation

and Social Events .......................................... 14-15

Exhibition and Sponsorship Opportunities ... 16-17

General Information ....................................... 18-19

Contacts and Venue Information .........................20

Important Dates and Deadlines

Deadline for Abstract Submission March 7, 2011

Notification to Abstract Authors Mid April, 2011

Deadline for Early Bird Registration Fee March 7, 2011

Deadline for Standard Registration Fee May 16, 2011

Deadline for Cancellation of Registration and Social Activities May 16, 2011

Deadline for Cancellation of Accommodation April 13, 2011

Last Date for Guaranteed Hotel Reservation April 13, 2011

3

Welcome

It is a pleasure for us, the Organising Committee, to welcome you all to the 3rd Pharmaceutical Sciences Fair and Exhibition. This event for the first time in Prague is co-organised by EUFEPS and a broad partner representation of 40 different international organisations and networks involved in Pharmaceutical Sciences.

The pharmaceutical world is changing dramatically, and an appealing scientific programme has been put together to address the Future of Medicines. In addition a Young Scientists Meeting is being organised during the 2011 PharmSciFair.

We are convinced of the need to carry the Pharmaceutical Sciences forward in this kind of global event, enabling all involved to think and consult together and to share experiences. The 2011 PharmSciFair, with around 1000 expected delegates, will allow us to understand the different approaches, perspectives and sensitivities among the different players in Pharmaceutical Sciences represented by delegates from academia, industry and regulatory. Building on the strengths of each and every actor, it ensures a consolidated movement towards common goals and targets and creates synergy within the array of different disciplines, all having the objective to better serve the Health.

At the Plenary Session, a prestigious group of influential leaders will contribute to a common vision of Pharmaceutical Sciences, in both the short and the long term.

The Pharmaceutical Sciences, as a multi-faceted concept is reflected at this event, which is wide-ranging in terms of scientific content, activities and participating parties.

You must be there and invite and welcome your colleagues to join as well!

Yours sincerely,

Dr Alain CuinéChair of the PharmSciFair Organising Committee

Committees and Acknowledgements

2011 PharmSciFair Organising Committee

Alain Cuine (Chair) [email protected] Bilensoy [email protected] Duchêne [email protected] Jadrijević-Mladar Takac [email protected] Kristl [email protected] Maitland-van der Zee [email protected] Samuelsson [email protected]

2011 PharmSciFair Programme Coordination

Erem Bilensoy [email protected] Jadrijević-Mladar Takac [email protected] H. Lindén [email protected]

EUFEPSEUFEPS Office [email protected]

4

• Advanced drug delivery• Advanced drug dosage forms• Adverse drug reactions• Adverse drug toxicity• Alternative animal tests• Analytical methods and instruments• Anti-counterfeiting• BCS based biowaivers• Bioanalysis• Bioavailability• Bioequivalence• Biomarkers• Biopharmaceuticals• Biosimilar medicines• Clinical implementation• Clinical pharmacy• Cyclodextrin-based drug delivery

• Design and optimisation of pharmaceuticals• Drug design• Drug development• Drug quality• Drug safety and safety sciences• Drug targeting• Environment and pharmaceuticals• Excipients• Excipients regulatory status, safety and efficacy• Genomics• Geriatric drugs• Industrial pharmacyeducation• Innovative medicines initiatives

• Intellectual property rights in pharmaceutical industry• Medicinal chemistry• Modified release dosage forms• Nanomedicine• Nanoparticles – therapeutic and diagnostic applications• Natural products• New therapeutic targets• Omics...• Paedriatic drugs• Parmaceutical technology, including molecular-based• Particulate products• Particulate systems for drug delivery

• Personalised medicines• Pharmaceutical care• Pharmaceutical sciences education and training• Pharmacoepidemiology• Pharmacogenetics and pharmacogenomics• Pharmacoepigenetics• Pharmacovigilance• Phytoequivalence• Presentation skills• Quality assurance• Quality by design and process analytical technology sciences• Regulatory sciences• Research and development in generic industry• Research practice

• Risk management• Scientific article reviewing• Scientific article writing• Swelling and dosage forms for oral delivery• System biology• Tailoring to route of administration• Therapeutic adherence and persistence • Vaccines

Domains and KeywordsAs submitting an abstract indicate domain, i.e. session or set of sessions as listed below and on the PharmSciFair Online.

The PharmSciFair Organising Committee welcomes the submission of abstracts for poster and oral presentations. Abstracts of scientific contributions relating to any topic in the pharmaceutical and related sciences will be considered for posters and short communications. Accepted abstracts will be published in the abstract book given to all participants.

SUBMISSION GUIDELINESGeneral InstructionsAbstracts should be submitted on the Internet at www.pharmscifair.org no later than March 7, 2011. Acknowledgement of receipt of submission will be sent to the stated email address under section “Contact details” within 24 hours. Notification on acceptance (and day for presentation) of the abstracts will be emailed to the contact person in Mid April 2011. The corresponding author will receive all correspondence

concerning the abstract. The corresponding author is responsible for informing the other authors of the status of the abstract. It is the author’s responsibility to submit a correct abstract; any errors in spelling, grammar, or scientific fact will be reproduced as typed by the author. You can follow the progress of your abstract online by using your Personal Page. Your Personal Page makes it possible for you to:• make changes until submission deadline• read and print your abstract• follow the status of your submitted abstract

From the PharmSciFair Online (www.pharmscifair.org) you can access your Personal Page by using your user id and password included in the email received upon submission.

Specificsn Abstracts must be written in English.n Write the title in lower case letters.n Maximum 200 words (1400 characters including spaces but excluding the title and the authors).n Make the abstract as informative as possible, including a brief statement of the purpose of the study, the method used, the result obtained, and the conclusion based upon the result.

n Do not include subtitles in the text.n The following information is requested for all authors: initial(s) for first name, family name(s), institution, department, city and country. n One author must be marked as the presenting author on the online submission form.n Double space between paragraphs and before the list of references.n Key reference should be stated under the body text of the abstract.

Also indicate keyword/s as suggested on the PharmSciFair Online and on the online abstract submission form.

Abstract Submission Deadline Abstracts should be submitted through the Internet at www.pharmscifair.org no later than March 7, 2011.

For submission support please contact Congrex at [email protected] or +46 8 4596600.

Call for Abstracts

Submission deadline March 7, 2011PharmSciFair Online www.pharmscifair.org

Keywords are listed on the PharmSciFair Online and on the On line abstract submission.

D

Time Tuesday Wednesday Thursday Friday

Sponsored Breakfast Sessions

Morning Parallel Sessions

Modified Release Dosage Forms Tailored to the Route of Administration: Advances in Pellet Technology: From Pellet Formation to Industrial Production(ADRITELF/AFI/APGI/TEFARCO Innova)

Assays for Selection and Evaluation of Therapeutic Antibodies(EAPB)

Nanomaterials for Drug Release and Delivery: New Materials and Manufacture(FPhS)

Vaccine Delivery: Routes of Administration(TI Pharma /EUFEPS)

Food and Drug Synergies: Hype or Hope?(EUFEPS BABP Network/FDS Network)

Nanoscience/Nanomedicine for the Benefit of the Patients(Young Scientist Meeting)

Parallel Sessions

Modified Release Dosage Forms Tailored to the Route of Administration: Transdermal and (Trans)mucosal Drug Delivery: From Research to Industrial Applications(ADRITELF/AFI/APGI/TEFARCO Innova)

Neglected Diseases(EFMC/FIP/EUFEPS)

Medicines Safety and Children(PSD)

Influence of Transporters on Drug Exposure and Drug-Drug Interactions(NVFW)

The Background of Patients, Healthcare Professionals and Scientists’ Consideration (EUFEPS Medicines for Everyone versus Medicines for Me)

Presenting the Future of Pharmacy in the Eyes of the Students(EPSA)

Parallel Sessions

Designing and Optimising Particulate Systems for Lung Delivery: Particle Engineering for Inhalation(ADRITELF/AFI/APGI/TEFARCO Innova)

Drug Discovery from Nature(GA Medicinal Plant and Natural Product Research/ÖPhG)

The Technology of Rare Diseases Treatment and Medicines in Therapy of Special Patients Groups(EUFEPS Medicines for Everyone versus Medicines for Me)

Biomaterials and Bioengineering: Biomimetic Approaches(SEFIG)

In silico Methods in Drug Research: from Idea to Medicine(SFD)

Pharmaceutical Process Modelling and Simulation(EUFEPS QbD and PAT Science Network)

Parallel Sessions

Harvesting Pharmacogenetics Today(EUFEPS PGPG Network)

Roundtable Discussion Session(EUFEPS Medicines for Everyone versus Medicines for Me)

Systems Biology: Catchword or New Paradigm(EUFEPS)

Progress of the Innovative Medicines Initiative (IMI)(IMI JU/EUFEPS)

Medical Devices: Scientific and Regulatory Progresses (TÜFTAD)

Benefits of PET in Drug Development(SRS/EANM)

Lunch - Poster and Exhibition Viewing

Sponsored Lunch Sessions

Panorama Presentation and Discussion



Mid Day Parallel Sessions

Innovative Strategies to Combat Neglected Diseases(EFMC)

New Harmonisation Procedures for Regulations and Current Practices for Clinical Trials(EAPB)

Nanomaterials for Drug Release and Delivery: Toxicity and Biological Interactions(FPhS)

Vaccine Delivery: Routes of Administration(TI Pharma/EUFEPS)

Tools in Biopharmaceutics(EUFEPS BABP Network)

Drug Discovery and Design: From Idea to Medicine(Young Scientist Meeting)

Pharmaceutical Sciences and Emerging Disease Patterns

Award Ceremony

EUFEPS 20th Anniversary Lectures and Celebration

Parallel Sessions

Designing and Optimising Particulate Systems for Lung Delivery: Barrier Transport in Lung Delivery(APGI/TEFARCO Innova)

Drug Discovery from Nature(GA Medicinal Plant and Natural Product Research/ÖPhG)

Model Based Drug Development through Systems Pharmacology(EUFEPS)

Dissolution and In vitro Bioequivalence (SEFIG)

Nanomedicine: From Bench to Batch: Development, Licensing, Marketing(TÜFTAD/EUFEPS NanoMedicine Network)

Pharmaceutical Process Modelling and Simulation(EUFEPS QbD and PAT Science Network)

Parallel Sessions

Hot Topics in Pharmacogenetics(EUFEPS PGPG Network)

Materials, Interfaces and Surfaces(APS)

Team Working(Special Workshop)

Effects and Risk Assessment(EUFEPS Environment and Pharmaceutical Network)

Benefits of PET in Drug Development(SRS/EANM)

Evening Free Evening PharmSciFair Networking Dinner Free Evening Breakdown of Exhibition and Posters

5

2011 PharmSciFair Preliminary Scientific Programme at a Glance

C

B

B

C

B

A

A

C

B

B

C

B

A

A

D

B

C

D

B

C

D

B

B

C

A

D

A B C D EDiscovery & Design Delivery & Body Process & Manufacturing Distribution & Use Exhibitor & Sponsor General & OtherF

F

F

C

F

B

F

F

B

A

B

B

A

Preliminary Programme

Scientific Programme Information

LanguageThe official language of the Conference is English. No simultaneous translation will be provided.

Certificate of AttendanceA certificate of attendance will be given to registered participants upon request.

Poster sessionsPoster viewing will be made

available during all coffee breaks (30 minutes in the morning and in the afternoon) and during the two hour lunch break.

Grants and/or fundingApplications for grants and/or support should be made at own discretion. There is no official PharmSciFair scholarship.

DisclaimerThe programme is correct at the time of the printing, however, the organisers reserve the right to alter

the programme if and as is deemed necessary. The PharmSciFair and/or its agents have the right for any reason beyond their control to alter or to cancel, without prior notice, the congress or any of the arrangements, time tables, plans or other items relating directly or indirectly to the PharmSciFair. The PharmSciFair and/or its agents shall not be liable for any loss, damage, expenditure or inconvenience caused as a result of such alteration or cancellation.

F

A

A

CC

6

SessionsTuesday, June 14

Partner ADRITELF/AFI/APGI/TEFARCO Innova

Partner EAPB Partner FPhS

09:00 Modified Release Dosage Forms Tailored to the Route of Administration: Advances in Pellet Technology: From Pellet Formation to Industrial Production

Assays for Selection and Evaluation of Therapeutic Antibodies

Nanomaterials for Drug Release and Delivery: New Materials and Manufacture

A particle’s view of pelletisation by extrusion-spheronisationD. Ian Wilson, University of Cambridge, Cambridge, United Kingdom

Protein microarrays in combination with cell based bioassays: Reliability for stability testing of therapeutic antibodiesMartin Blueggel, Protagen AG, Dortmund, Germany

Ocular nanoparticle mediated drug and gene deliveryArto Urtti, University of Helsinki, Helsinki, Finland

Understanding the pellettisation process at the industrial level: Formation and productionPaul Heng, University of Singapore, Singapore, Singapore

’Simply the best, better than all the rest...’: How to select the optimal therapeutic antibody candidateSteffen Hartmann, Novartis Pharma AG, Basel, Switzerland

Mesoporous silicon as a multifunctional drug carrierVesa-Pekka Lehto, University of Eastern Finland, Kuopio, Finland

10:20 Break

10:40 Short Communication Short Communication Nanoconfinement of poorly soluble drugs in porous silicon: Physical state and dissolutionJoakim Riikonen, University of Eastern Finland, Kuopio, Finland

Short Communication Short Communication Bionanomaterials in pharmaceutical formulationsHanna Valo, University of Helsinki, Helsinki, Finland

Short Communication Short Communication Short Communication


12:00 Lunch - Poster and Exhibition Viewing

Panorama Presentation and Discussion on Access to Medicinal Products in Europe: Innovation and Healthcare

Partner EFMC Partner EAPB Partner FPhS

14:30 Innovative Strategies to Combat Neglected Diseases

New Harmonisation Procedures for Regulations and Current Practices for Clinical Trials

Nanomaterials for Drug Release and Delivery: Toxicity and Biological Interactions

Virtual library design, screening and synthesis of new potential antitubercular compoundsMaurizo Botta, Universtity of Siena, Siena, Italy

The voluntary harmonisation procedure Heiko E. von der Leyen, Hannover Clinical Trial Center GmbH, Hannover, Germany

BioNanoInteractions: A rational approach to nanomedicine and nanosafety? Kenneth Dawson, University College Dublin, Dublin, Ireland

Quinolonamides against trypanosoma brucei Ulrike Holzgrabe, Universtity of Würzburg, Würzburg, Germany

Harmonisation of requests of the ethic committee Speaker to be announced

Modular nanocarriers for drug delivery and their potential to cross biological barriersMarc Schneider, Saarland University, Saarbrücken, Germany

Short Communication

15:50 Break

16:10 Developing drugs for neglected diseases: Current challenges and opportunitiesSimon Croft, London School of Hygiene and Tropical Medicine, London, United Kingdom

Harmonisation of requests of the ethic committeeJoerg Hasford, Ludwig-Maximilians-University, Munich, Germany

Biocompatible functionalisation of silicon nanoparticlesLuis Bimbo, University of Helsinki, Helsinki, Finland

Multi-target-directed ligands as innovative tools to combat trypanosomatid diseasesMaria Laura Bolognesi, Universtity of Bologna, Bologna, Italy

Short Communication Short Communication

17:30

ChemSpider: Integrating and curating Internet-based chemistry resources to serve life scientistsAnthony Williams, RSC/ChemSpider, Raleigh-Durham, NC USA


C B

A C B

Young Scientist MeetingContinuing the concept of the very successful Young Scientists Meetings at the PSWC2007 in Amsterdam, and at the 2009 PharmSciFair in Nice, also in the 2011 PharmSciFair in Prague the Young Scientists Meeting will be organised for the next generation of pharmaceutical scientists. It will take place at the same time, place and venue as the PharmSciFair. The Young Scientists Meeting aims to bring together academic scientists, leading

engineers, industry researchers and students.Young scientists will present their work orally or as poster presentationsThe time slots for oral presentations are 20 minutes. Posters will be categorised for round poster discussion groups, covering common topics: Medicinal Chemistry/Target Discovery, Drug Delivery/Biology, Drug Delivery/Technology, Clinical Pharmacy/Pharmacokinetics/Pharmakodynamics/

Pharmacoepidemiology, Drug Transport/Drug Metabolism, Toxicology/Safety, Pharmaceutical Analysis/Bioanalysis/Quality assurance/Regulatory Affairs. To initiate the discussion and debate invited moderators will introduce the topic, which will be followed by students' oral presentations in front of their posters (5 min), questions and discussions. It is important to stress that each Young Scientist will have the >>>

C

7

SessionsTuesday, June 14

Partner TI Pharma/EUFEPS Partner EUFEPS BABP Network/FDS Network

Young Scientist Meeting

09:00 Vaccine Delivery: Routes of Administration

Food and Drug Synergies: Hype or Hope?

Nanoscience/Nanomedicine for the Benefit of the Patients

The lymphatic system and DC traffickingIraklis Kourtis, EPFL Lausanne, Lausanne, Switzerland

Food-Drug Synergies: What are they and how do we exploit them? Perspectives from the Øresund regionDavid Featherston, University of Copenhagen, Copenhagen, Denmark

Short Communication

Intralymphatic delivery versus other invasive routes Pål Johansen, University Hospital Zurich, Zurich, Switzerland

Topic to be announcedCharles Frey, The Coating Place, Verona, WI USA

Short Communication

10:20 Break

10:40 Oral delivery Juan Irache, University of Navarra, Navarra, Spain

Sensory liking and acceptancePer Møller, Faculty of Life Sciences, University of Copenhagen, Copenhagen, Denmark

Short Communication

Short Communication Topic to be announcedDaniel Bar-Shalom, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark Anette Müllertz, Bioneer: FARMA, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark

Short Communication

Short Communication



Partner TI Pharma/EUFEPS Partner EUFEPS BABP Network Young Scientist Meeting

14:30 Vaccine Delivery: Routes of Administration

Tools in Biopharmaceutics Drug Discovery and Design: From Idea to Medicine

Transcutaneous deliveryAnne Moore, University College Cork, Cork, Ireland

PK/PD modelling and simulations: Scientific approaches for the best therapeutic outcomes of future medicinesAmin Rostami-Hodjegan, Simcyp and School of Pharmacy and Pharmaceutical Sciences, Manchester, United Kingdom

Short Communication

Transcutaneous deliveryJoke Bouwstra, Leiden University, Leiden, The Netherlands

Compatibility of systems for food and pharma applicationsEvelijn Zeijdner, TNO Quality of Life, Zeist, The Netherlands

Short Communication

15:50 Break

16:10 Nasal deliveryWim Jiskoot, Leiden University, Leiden, The Netherlands

Quantitative regional drug absorption in dogs with IntelliCap systemDieter Becker, Novartis Pharma AG, Basel, Switzerland

Short Communication

17:30

Pulmonary delivery Richard Thomas, Defence Science & Technology Laboratory, Salisbury, United Kingdom

Intelligent oral drug delivery solutions for the futureJeff Shimizu, Philips Medimetrics, Eindhoven, The Netherlands

Short Communication

Young Scientist Meeting, continuedopportunity to present research work orally and benefit from interaction with each other. The most outstanding oral and poster presentation in each group will be honoured with a “Young Investigator Award”.

Reasons to attend the Young Scientist MeetingDiscover the latest research and technologies, study the different

approaches taken to develop future medicines, and network with leaders from academia and industry sectors in a relaxed and informal atmosphere, ideal for the creative exchange of ideas and the development of new collaborative projects.

Call for Abstracts – Young Scientist MeetingYoung Scientists are invited to submit

an abstract to the Young Scientists Meeting or to PharmSciFair. Instructions for abstract submission are available under Call for Abstracts. After submission abstracts will be reviewed and classified as oral or poster presentation and the authors will receive a notification in mid-April.

* Topics may be subject to change

>>>

C

B B A

B A

C

B

8

SessionsWednesday, June 15


Partner EFMC/FIP/EUFEPS Partner PSD

09:00 Modified Release Dosage Forms Tailored to the Route of Administration: Transdermal and (Trans)mucosal Drug Delivery: From Research to Industrial Applications

Neglected Diseases Medicines Safety and Children

Transdermal technology for drug deliveryRichard H. Guy, University of Bath, Bath, United Kingdom

Session programme in progress Trends in use of antipsychotic medicine among Dutch youths: Implications for off-label use, efficacy and safety Hilde Toby, Wageningen University, Wageningen, The NetherlandsBioadhesive films for transdermal and buccal

applicationPatrizia Santi, University of Parma, Parma, Italy

Prescribing of psychotropic medicines in a child and adolescent psychiatry departmentEbba Holme Hansen, University of Copenhagen, Copenhagen, Denmark

10:20 Break

10:40 Therapeutic platforms for the treatment of mucosal lesionsCarla M. Caramella, University of Pavia, Pavia, Italy

Session programme continued Characteristics of adverse drug reactions related to off-label prescribing in the Danish paediatric populationLise Aagaard, University of Copenhagen, Copenhagen, Denmark

Short Communication From safety warnings to implementation of rational monitoring in pediatric psychotropic treatmentLuuk J. Kalverdijk, University Medical Center Groningen (UMCG), Department of Psychiatry and Department of Pediatrics Groningen, The Netherlands

Short Communication


14:00 2011 PharmSciFair Plenary Session


Addressing the role and contributions of pharmaceutical sciences in combating emerging diseases & highlighting future opportunities and challenges in this important field.

Yesterday, Today, TomorrowChristian R. Noe, University of Vienna, Vienna, Austria

The rise of omicsIngolf Cascorbi, Kiel University, Kiel, Germany

Big molecules: What do they promise?Tudor Arvinte, Therapeomic, Geneva, Switzerland

Regulatory issues in reacting to emerging diseasesSpeaker to be announced

17:30

Award Ceremony


EUFEPS and contributions to dateEUFEPS Speaker Visions in pharmaceutical sciences … and outcomesTrevor M. Jones, Technogen, London, United Kingdom

PharmSciFair Networking Dinner

A D

F

C

9

SessionsWednesday, June 15

Partner NVFW Partner EUFEPS Medicines for Everyone versus Medicines for Me

Partner EPSA

09:00 Influence of Transporters on Drug Exposure and Drug-Drug Interactions

The Background of Patients, Healthcare Professionals and Scientists’ Consideration

Presenting the Future of Pharmacy in the Eyes of the Students

Relevance of liver and kidney transporters for drug exposureFrans G.M. Russel, Department Pharmacology and Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

The influence of patient interest groupsMarita Pohlschmidt, Muscular Dystrophy Campaign, London, United Kingdom

Pharmine: A change for good?João Eduardo da Silva Duarte, EPSA, Lisbon, Portugal

Relevance of intestinal transporters for drug absorption and gut extractionAnna-Lena Ungell, AstraZeneca Mölndal, Mölndal, Sweden

The need for personalised medicinesDavid Thurston, The School of Pharmacy, University of London, London, United Kingdom

Individual mobility project: Opening students’ doors to a successful careerJurij Obreza, EPSA, Ljubljana, Slovenia

10:20 Break

10:40 ABC transporters: The in vitro toolbox and in vitro–in vivo correlations (IVIVC)Peter Krajcsi, Solvo Biotechnology, Budapest/Szeged, Hungary

Organoleptics for young and oldDaniel Bar-Shalom, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark

EPSA training projectInkatuuli Heikkinen, EPSA, Helsinki, Finland

Short Communication PK/PD considerationsMeindert Danhof, Centre for Bio-Pharmaceutical Sciences, Leiden University, Leiden, The Netherlands

Presentation of the winning project of the 3rd EPSA science saySpeaker to be announcedShort Communication


14:00 2011 PharmSciFair Plenary Session


Addressing the role and contributions of pharmaceutical sciences in combating emerging diseases & highlighting future opportunities and challenges in this important field.

Yesterday, Today, TomorrowChristian R. Noe, University of Vienna, Vienna, Austria

The rise of omicsIngolf Cascorbi, Kiel University, Kiel, Germany

Big molecules: What do they promise?Tudor Arvinte, Therapeomic, Geneva, Switzerland

Regulatory issues in reacting to emerging diseasesSpeaker to be announced

17:30

Award Ceremony


EUFEPS and contributions to dateEUFEPS Speaker Visions in pharmaceutical sciences … and outcomesTrevor M. Jones, Technogen, London, United Kingdom

PharmSciFair Networking Dinner

B D F

F

10

SessionsThursday, June 16


Partner GA Medicinal Plant and Natural Product Research/ÖPhG

Partner EUFEPS Medicines for Everyone versus Medicines for Me

09:00 Designing and Optimising Particulate Systems for Lung Delivery: Particle Engineering for Inhalation

Drug Discovery from Nature The Technology of Rare Diseases Treatment and Medicines in Therapy of Special Patients Groups

Spray-dried particles: From fundamentals to inhalationNicolas Tsapis, Université de Paris Sud, Châtenay Malabry, France

Generating novel medicinal plants for the heterologous biosynthesis of secondary natural products Oliver Kayser, Technical Biochemistry, Technical University Dortmund, Dortmund , Germany

The orphan diseasesSpeaker to be announced

Generating novel medicinal plants for the production of recombinant therapeuticsHeribert Warzecha, Plant Biotechnology and Metabolic Engineering, Technical University Darmstadt, Darmstadt, Germany

The Edry and Edisp technologies. Particles engineered for dry and liquid lung deliveryGiovanni Caponetti, Eratech S.r.l., Piacenza, Italy

Polypharmacology with natural products:Challenges and chances for drug discoveryJürg Gertsch, Institute of Biochemistry andMolecular Medicine, University of Bern, Bern,Switzerland

Commercial approaches to individualised dosesGino Martini, Strategic Technologies GSK, Essex, United Kingdom

10:20 Break

10:40 Short Communication Natural compounds and their analogues as inhibitors of sodium/glucose co-transporters in the treatment of diabetesWolfgang Blaschek, Pharmaceutical Biology, Institute of Pharmacy, University of Kiel, Kiel, Germany

Multicomponent systems: Fixed dose and variable dose combinedDaniel Bar-Shalom, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark

Short Communication Advanced therapies: Cell somatic therapies and regenerative medicineSpeaker to be announced

Short Communication Pharmacological inhibitors of disease-relevant protein kinases: Selected examplesLaurent Meijer, CNRS, Station Biologique and ManRos Therapeutics, Roscoff, France

Short Communication




Partner APGI/TEFARCO Innova Partner GA Medicinal Plant and Natural Product Research/ÖPhG

Partner EUFEPS

14:30 Designing and Optimising Particulate Systems for Lung Delivery: Barrier Transport in Lung Delivery

Drug Discovery from Nature Model Based Drug Development through Systems Pharmacology

Lung and nanotoxicology of biodegradable particlesElias Fattal, Université de Paris Sud, Châtenay Malabry, France

Natural products as leads and tools in cardiovascular researchVerena Dirsch, Faculty of Life Sciences, University of Vienna, Vienna, Austria

Setting the Scene: Systems pharmacology from an academic perspectiveHarrie C.M. Boonen, Faculty of Pharmaceutical Sciences, Copenhagen University, Denmark

Biopharmaceutics and inhalation Stuart Jones

Computer-based predictions of natural compound bioactivities: Concept and recent success storiesDaniela Schuster, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria

Mechanism based PK-PD modellingMeindert Danhof, Faculty of Science, Leiden/Amsterdam Centre for Drug Research, Leiden, The Netherlands

Modelling, simulation and systems pharmacology in drug development, an industry perspectiveDon Stanski, Novartis Pharmaceuticals Corporation, East Hannover NJ USA

15:50 Break

16:10 Short Communication Contributions of NMR to the advance of pharmaceutical sciencesManfred Spraul, Bruker BioSpin GmbH, Rheinstetten, Germany

Glycosaminoglycan-protein interactionsBernd Gesslbauer, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria

Chronotherapy modelling and simulationFrancis Levi, Université Paris XI, Hôpital Paul Brousse, Villejuif, FranceShort Communication

Regulatory implications for translation and clinical workLarry J. Lesko, FDA Center for Drug Evaluation and Research, Silver Spring MD USA

Short Communication Green systems biology: From single genomes, proteomes and metabolomes to ecosystems and biotechnology Wolfram Weckwerth, Department of Molecular Systems Biology, University of Vienna, Vienna, Austria

Discussion

17:30

Short Communication

B C D

B A A

11

SessionsThursday, June 16

Partner SEFIG Partner SFD Partner EUFEPS QbD and PAT Science Network

09:00 Biomaterials and Bioengineering: Biomimetic Approaches

In silico Methods in Drug Research: from Idea to Medicine

Pharmaceutical Process Modelling and Simulation

Short Communication Discovery of new enzyme inhibitors by virtual screening Stanislav Gobec, University of Ljubljana, Ljubljana, Slovenia

Numerical tools for the simulation of key pharmaceutical processesJohannes G. Khinast, Graz University of Technology, Graz, AustriaShort Communication

Short Communication Mathematical modelling of interindividual variability in drug response Grabnar Iztok, University of Ljubljana, Ljubljana, Slovenia

Mathematical modelling as a tool for pharmaceutical process understanding and designFrantisek Stepanek, Institute of Chemical Technology, Prague, Czech Republic

Short Communication

10:20 Break

10:40 Short Communication Virtual fragment-based molecular design approaches in the discovery of new anti-infectives Colin W.G. Fishwick, University of Leeds, School of Chemistry, Leeds, United Kingdom

Quality by design approach in coating Kaisa Naelapää, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark

Short Communication

Understanding hypercholesteremia through modelling and simulation Aleš Belic, University of Ljubljana, Ljubljana, Slovenia

Short Communication Numerical modelling of technological processes Rok Dreu, University of Ljubljana, Ljubljana, Slovenia

Short Communication




Partner SEFIG Partner TÜFTAD/ EUFEPS NanoMedicine Network

Partner EUFEPS QbD and PAT Sciences Network

14:30 Dissolution and In vitro Bioequivalence

Nanomedicine: From Bench to Batch: Development, Licensing, Marketing

Pharmaceutical Process Modelling and Simulation

Short Communication The science and regulation of nanoparticles: An FDA perspectiveMansoor Khan, US Food and Drug Administration FDA/CDER, Maryland, USA

Molecular modelling in the formulation development of amorphous drugsOssi Korhonen, School of Pharmacy/PROMIS Centre, University of Eastern Finland, Kuopio, Finland

Short Communication

Short Communication Regulatory approach to nanomedicine: European perspectiveHeidi Foth, University of Halle, Halle, Germany

Short Communication


15:50 Break

16:10 Short Communication Design and in vitro-in vivo testing of cationic nanocarriers loaded with chemo- or immunotherapeutics for treatment of bladder cancerErem Bilensoy, Hacettepe University Faculty of Pharmacy, Ankara, Turkey

Recent developments within chemometricsHamid Babamoradi, Faculty of Life Sciences, University of Copenhagen, Copenhagen, DenmarkShort Communication

17:30

Short Communication Industrial perspective for the development and marketing of nanomedicineSimon Benita, Hebrew University of Jerusalem, Novagali Pharma, NanoLymf Ltd, Jerusalem, Israel

Short Communication


B A C

B CC

12

SessionsFriday, June 17

Partner EUFEPS PGPG Network Partner EUFEPS Medicines for Everyone versus Medicines for Me

Partner EUFEPS

09:00 Harvesting Pharmacogenetics Today

Roundtable Discussion Session Systems Biology: Catchword or New Paradigm

Biomarkers and genetics in cancer Andrew Freedman, National Cancer Institute, NIH, Bethesda, MD USA

Session programme in progress Discussion topic: How to foster pharmaceutical research in Europe and improve medicines access?Short introductions and discussion to which all present are invited to contribute.

Role of angiogenic monocytes in cancer: an experimental and computational approachIoannis Xenarios, Swiss Institute of Bioinformatics, Swiss-Prot Group, Geneva, Switzerland

Antithrombotics: The case of clopidogrel Céline Verstuijft, Université Paris-Sud, Châtenay Malabry, France

Life is complex; and so should drugs and therapies be; the network approach to drug target design and toxicity reliefHans Westerhoff, Centre for Integrative Systems Biology, University of Manchester, Manchester, United Kingdom

10:20 Break

10:40 Pharmacogenetics of immunosuppressants Dennis Hesselink, Erasmus Medical Center, Rotterdam, The Netherlands

Session programme continued Topic to be announced Speaker to be announced

Adverse drug reactions Ana Alfirevic, University of Liverpool, Liverpool, United Kingdom

Topic to be announced Speaker to be announced



Partner EUFEPS PGPG Network Partner APS Special Workshop

14:30 Hot Topics in Pharmacogenetics Materials, Interfaces and Surfaces Team Working

Clinical trials on coumarinsAnke-Hilse Maitland-van der Zee, Utrecht University, Utrecht, The Netherlands

Introduction to nanoparticles and sessionJayne Lawrence, Kings College London, London, United Kingdom

Buket Aksu, EGE University, Izmir & Santa Farma Pharmaceuticals, Istanbul, Turkey Games that require team work will beutilised to illustrate important aspects. Selfknowledge is the first one of all steps. Getting to know the other on the team is the second; it helps to understand. Good team work, also calls for good organisation of all information available. For young scientists’ team working skills are useful for future successes, whether their goal is to work in industry or academia.Attend the workshop, expand your insighteducation, and take advantage of networkingopportunities.

Next generation sequencing in PharmacogenomicsWolfgang Sadee, The Ohio State University, Columbus Ohio, USA

Polymeric siRNA nanocarriers for antiarthritic therapy: From physicochemical characterisation to in vivo imagingCamilla Foged, University of Copenhagen, Copenhagen, Denmark

15:50 Break

16:10 Epigenetics in drug resistanceIngolf Cascorbi, University of Kiel, Kiel, Germany

Cristal delivery: Development of a novel nanoparticle drug delivery conceptCristianne J.F. Rijcken, Cristal Delivery, Utrecht, The Netherlands

Session programme continued

Nanomedicine development for delivery of combination therapiesTwan Lammers, Research Fellow, University of Utrecht, The Netherlands

17:30

What do we learn from meta-analyses in pharmacogeneticsBruno Stricker, Erasmus Medical Center, Rotterdam, The Netherlands

Short Communication

Short Communication

D F A

D B F

13

SessionsFriday, June 17

Partner IMI JU/EUFEPS Partner TÜFTAD Partner SRS/EANM

09:00 Progress of the Innovative Medicines Initiative (IMI)

Medical Devices: Scientific and Regulatory Progresses

Benefits of PET in Drug Development

Session programme in progress

The Innovative Medicines Initiative (IMI) is the unique and large-scale public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The IMI programme (€ 2 billion) aims to speed up the discovery and development of safer and more effective drugs for patients, and to reinvigorate the biopharmaceutical sector in Europe. It supports projects in the following pre-competitive areas: Predicting safety; predicting efficacy; knowledge management; and education and training. Progress and status as of June 2011 will be presented.

Session programme in progress Medical devices have substantial impact on health and health care expenditure. Furthermore, innovation and rapid advancement of technologies contributed to one of the fastest growing industries and global markets. The regulatory aspects of medical devices differ from country to country. Different risk based classes of medical devices require proportional regulatory controls. Increasing collaboration and cooperation between the medicines and devices regulatory systems will be required. In the session, these aspects will be addressed.

Possibilities of PET in drug research Heinz H. Coenen, Forschungszentrum Jülich, Germany

PET: enabling confident decisions to guide efficient drug developmentEric Hostetler, Merck, USA

10:20 Break

10:40 Session programme continued Session programme continued Planning for PET inclusion in Entry-Into-Human trials in oncologyMats Bergström, Roche, Switzerland

Novel markers for imaging Parkinson and Alzheimer diseasesGilles Tamagnon, Molecular NeuroImaging, USA



Partner EUFEPS Environment and Pharmaceutical Network

Partner SRS/EANM Partner SRS/EANM

14:30 Effects and Risk Assessment Benefits of PET in Drug Development

Benefits of PET in Drug Development

Do pharmaceuticals have side effects on the environment?Alistair Boxall, University of York, Heslington, United Kingdom

Morning session programme continued Success stories from academiaChrister Halldin, Karolinska Institutet, Sweden

Perspectives from radiopharmaceutical industryAndrea Thiele, Bayer, Germany Human pharmaceuticals: Occurrence and

elimination in sewage treatment plants and potential presence in surface waters Bent Halling-Soerensen, University of Copenhagen, Copenhagen

15:50 Break

16:10 Environmental EFFECTS causally related to exposure to single or mixtures of pharmaceuticals (human and veterinary)Ross Brown, AstraZeneca, Brixham Environmental Laboratory, United Kingdom

Big pharma perspectivesEugenii A. Rabbiner, GSK, United Kingdom

17:30

Risk assessment of pharmaceuticals in the environment: The Swedish environmental classification system for pharmaceuticalsChristina Rudén, School of Architecture and Built Environment, Royal Institute of Technology, Stockholm, Sweden

Regulatory issues of PET in drug developmentAlfons Verbruggen, University of Leuven, Belgium

F A B

BF

14

Registration, Accommodation and Social Events

Registration Fees

Members Standard (non-members)

Early Bird Fee

Mid Fee Late On-site Fee

2-Day-Card Early Bird Fee

Mid Fee Late On-site Fee

2-Day-Card

Before/on March 7, 2011

March 8 - May 16, 2011

After May 16, 2011

Before/on March 7, 2011

March 8 - May 16, 2011

After May 16, 2011

Full week registration






Industry 950 1100 1300 890 1100 1300 1500 900

Academia/Governmental

700 800 900 610 800 900 1000 700

Student 300 350 400 250 350 400 450 300

Accompanying Guests

50 50 50 n/a 50 50 50 n/a

* All fees are in EUR and are inclusive of 20% VAT and daily tea/coffee. If your payment is not received by the deadline dates, the higher fee will automatically be charged.

Please use the on-line registration form, available on www.pharmscifair.org

Standard and Member Fees (**)The registration fees include admission to all 2011 PharmSciFair events, including the Plenary Session, the Awards Ceremony and EUFEPS 20th Anniversary on Wednesday afternoon, the Welcome Reception, the Commercial and Poster Exhibitions as well as daily coffee breaks. Please be informed that separate registration to some social activities and Industry Sponsored Symposia may have to be made separately, and spaces are available upon first-come first-served basis. The member fee will apply for members of EUFEPS and of all partner societies. A complete list is available on the on-line registration. 2-Day cards can be purchased for two consecutive days, only, and selected days shall be indicated on the on-line registration form. Delegates with 2-Day cards may only attend sessions and social activities on the given days. Delegates with a non-valid 2-Day card will not be allowed admission to the PharmSciFair programme or social activities.

Student FeeDelegates applying for student fees should supply proof of their student status (e.g. a photocopy of the university identity card).

Accompanying GuestsAccompanying Guests are welcome to attend the Welcome Reception on Monday evening, the PharmSciFair Plenary Session and Awards Ceremony as well as the EUFEPS 20th Anniversary celebrations on

Wednesday afternoon. Registered Accompanying Guests are welcome to register to the PharmSciFair social activities and tours. Spaces are available on a first-come first-served basis. Please note that the Accompanying Guest registration does not include admission to the Scientific Sessions, The Commercial and Poster Exhibitions, nor does it include the PharmSciFair Programme book and/or any coffee breaks.

Press and Media RegistrationPharmSciFair welcome accredited Press delegates. Please contact the Official Conference Organisers, Congrex, for further details and registration, [email protected] or +46 8 4596600. Press registration is not available on the on-line registration form.

Exhibitor RegistrationExhibitor registrations are purely booth staff registrations and will not include admission to the Scientific Sessions. Exhibitor registrations include daily coffee breaks and the Welcome Reception

on Monday evening. Exhibitors/booth staff registrations are booked in conjunction with the Exhibition stand directly with the Official Conference Organiser, Congrex. Please contact Congrex for further information [email protected]. Exhibitor registration is not available on the on-line registration form.

Group RatesGroup rates should be considered when a number of delegates from the same organisation register simultaneously. Please contact Congrex for further information and rates. Please note that group registration is made separately and is not available on the on-line registration form.

Registration for Abstract PresentersAll delegates intending to participate in the 2011 PharmSciFair are advised to register at their earliest convenience, however delegates with an exepted Abstract (poster or oral presentation), who have not yet registered will be accepted for the Early bird registration fee.

15

AccommodationA number of rooms in different price categories have been booked in Prague. Hotel reservation can be made only when registering for the 2011 PharmSciFair, on the on-line registration form. All accommodation requests will be handled on a first-come first-served basis and Congrex reserves the right to remove sold-out hotels from the booking form, if registering late. Congrex guarantees availability until April 13, 2011. New accommodation requests will be accepted thereafter, and confirmed upon availability. Full pre-payment is mandatory to make and guarantee your reservation.

Hotel Name Single room/night

Double room/night

Best Western Hotel Meteor Plaza

EUR 115 EUR 125

Chopin Hotel EUR 120 EUR 120

Coronet Hotel EUR 149 EUR 149

Rezidence Vyšehrad *

EUR 149 EUR 149

Hilton Prague Old Town

EUR 228 EUR 234

Holiday Inn Prague Congress *

EUR 175 EUR 197

Park Inn Prague EUR 125 EUR 125

All rates are inclusive of 10% VAT, and breakfast.

* Adjacent/close to the 2011 PharmSciFair venue.

Registration and Accommodation SupportCongrex will be responsible for all communication with participants. For registration and/or accommodation support (queries, concerns, payment issues, availabilities and/or waitlist etc.) please contact Congrex, [email protected] or +46 8 4596600.

Social EventsSeveral social events are being planned in conjunction to the Scientific Sessions. Registration should be made on the on-line registration form and spaces will be allocated on a first-come first-served basis.

PharmSciFair Welcome ReceptionThe PharmSciFair Welcome Reception will take place at the Forum Hall Foyers 1 and 2, in the commercial and poster exhibitions, at 18:30 on Monday evening June 13, 2011. Admission to the Welcome Reception is complimentary to registered Delegates and Accompanying Guests and attendance should be marked on the on-line registration form.

PharmSciFair Networking DinnerThe PharmSciFair Networking Dinner is scheduled for Wednesday evening June 15, 2011. Further information will be available on the on-line registration, where attendance should be marked.

Tours ProgrammeA number of interesting tours will be offered, and further information will be available on the on-line registration, where attendance should be marked.

Please note that the PharmSciFair Dinner and the pre-arranged tours must be selected at the on-line registration form and comes with an additional cost.

MealsDaily tea and coffee breaks will be included on the days you are registered for.

Lunch is not included in the registration fees, however Industry Sponsored Symposia may be available where light lunches is likely to be served. Information on and registration to such events will be sent to you separately by the Industry Sponsor, via the

Organisers. Please carefully read the data protection section on the registration form, should you wish to receive invitation(s) to such events.

Reservations and Payment PolicyDelegates will receive a confirmation from Congrex, once their registration and accommodation request has been processed. All Delegates are requested to read this carefully as it includes a receipt, summary and useful information. Full pre-payment for registration and accommodation is mandatory. Congrex reserves the right to apply the higher registration fee, should payment not have been received before/on the deadline date. Congrex reserves the right to cancel hotel reservations should pre-payment not have been settled before/on April 13, 2011 or within 5 working days after the reservation is being made. Pre-payment can be made by major credit cards, VISA, MasterCard/EuroCard and AMEX via a secure payment link, provided by DIBS. Pre-payment via bank transfer is possible until May 23, 2011. Further details are available on the on-line registration link.

Cancellation and Refund PolicyNotification of cancellation must be made in writing and sent to Congrex. Cancellation of accommodation will be accepted until April 13, 2011, and cancellation of registration and social activities will be accepted until May 16, 2011, up to which dates the total amount will be refunded less a handling fee of 50 EUR. For cancellations made after the above given dates no refunds can be made.

16

Forum Hall Foyer, 1st FloorStands 1.1 – 1.12 are 3 sqm Stands 1.13 – 1.19 are 6 sqmMaximum building height: 2.8 m. n Stand area n Catering point

Forum Hall Foyer, 2nd FloorMaximum building height: 2.8 m. Maximum building height: 11 m (stands 2.18-2.25)

Exhibition and Sponsorship Opportunities

17

PharmSciFair is the Premier European Platform for Advancing Pharmaceutical Sciences where pharmaceutical scientists from different disciplines gather to share recent findings and to discuss further activities to strengthen the pharmaceutical sciences in Europe. Exhibitors and Sponsors will be given the perfect opportunity to interact with delegates from various organisations within the Pharmaceutical Sciences field, and given the audience of the previous PharmSciFair in 2005 and 2009, we expected audience is approximately 1000 delegates.

Exhibition Information and PackageA commercial exhibition will be arranged in conjunction to the scientific sessions, at the 1st and 2nd floors of the Forum Hall Foyer, at the Prague Congress Centre. The general thought is to integrate the commercial exhibition with the poster exhibition as well as the catering services, in order to maximise the exhibitor’s interaction with the delegates. The Forum Foyers will serve as the main catering area, where morning- and afternoon coffee breaks will be served, and also be the foundation for the Welcome Reception on Monday afternoon. The exhibition will be open for the duration of the meeting, starting with the Welcome Reception on Monday evening June 13th, and close on Friday afternoon. Large exhibition stands are 2 by 3 square metres and small exhibition stands are 1 by 3 metres.

The charge for floor space is EUR 400 per square meter (excluding VAT) The charge is for floor space only, exclusive of carpet, walls, electricity, etc. All exhibitors must bring their own equipment or make an order through the contracted supplier. Order forms and contact details to the contracted supplier will be forwarded by the Organisers to confirmed exhibitors.

Floor space rental includes:n daily cleaning of aisles and common areasn general lighting for all the event areasn 1 free Exhibitor (booth staff) registration (including daily tea and coffee breaks) per 3 sqm exhibition stand plus 1 delegate bag per exhibiting company. **

n 2 free Exhibitor (booth staff) registrations (including daily tea and coffee breaks) per 6 sqm exhibition stand plus 2 delegate bags per exhibiting company. **

** Note that Exhibitor registrations do not get access to the Scientific Programme Sessions.

Further information on Exhibition may be obtained from the Exhibition and Sponsorship Invitation, available at www.pharmscifar.org or by contacting the Official Conference Organiser, Congrex, [email protected] or +46 8 4596600

Several Sponsorship packages are available, from Diamond Sponsorship (50 000 EUR) to Silver Sponsorship (10 000). New for the 2011 PharmSciFair is that the Organisers have opened for the opportunity to host Industry Sponsored Breakfast and/or Lunch Session. Session halls will be available in the early mornings and during lunchtime and time periods of up to 45 minutes will be allocated to Sponsors, outside the main scientific programme. There is also a wide and exiting

range of other Sponsorship Items, such as advertising in printed material and/or on the website, commodities like pens, notepads and name badge holders/lanyards, opportunities for signage and flyers/bag inserts as well as food and beverage sponsorship, networking opportunities and social event sponsorship. All Sponsors of the 3rd PharmSciFair will be given the perfect opportunity to be seen at this front-edge event, the platform for Innovation within the

Pharmaceutical Sciences field, and to be associated with the 3rd PharmSciFair – Pharmaceutical Sciences for the Future of Medicines.

Further information on Sponsorship may be obtained from the Exhibition and Sponsorship Invitation, available at www.pharmscifar.org or by contacting the Official Conference Organiser, Congrex, [email protected] or +46 8 4596600

Sponsorship Opportunities

18

General Information

Airport and Local TransportationThe Ruzyne International Airport is located 18 kilometres from the Prague Congress Centre. The centre can be reached by taxi or public transport.

A shuttle bus links the airport and the end station of the “A” metro line named Dejvická. It runs every 30 minutes. From Dejvická take the Skalka-bound service to the Muzeum stop, there change to line C, running in the direction of Háje. Get off at the Vyšehrad metro stop (it is the second stop after Muzeum). The Congress Centre is located right next to the metro stop. The combined bus-metro service will take you to the Congress Centre from the airport in approximately 45 minutes.

TaxiProviding you are taking taxi the journey will take you about 25 minutes. Please note that not all Taxis in Prague are able to accept payment by credit cards.

By BusIf you decide to arrive by bus, most of the Prague-bound international links terminate at the Florence station, which is about 10 minutes far away by metro. Get off at the Vyšehrad stop. (It is the fourth stop from Florence). The Congress Centre is located right next to the stop.

By TrainHaving once arrived at the Prague Main Station (Hlavní nádraží), take the metro from the Hlavní nádraží stop running in the direction of Háje. Get off at the Vyšehrad stop (it is the third stop from Hlavní nádraží). The Congress Centre is located right next to the stop.

BadgesEach participant will receive a name badge upon on-site registration. For security reasons all delegates are requested to wear their name badge during all PharmSciFair activities.

Banks and Post OfficesMost banks and post offices are open from Monday to Friday between 09:00-16:00. All banks in Czech Republic exchange foreign currency and traveller's cheques.

Exchange of foreign currency is also available at Prague International Airport and at most hotels, banks and exchange offices throughout the city. International credit cards are accepted for payments in hotels, restaurants and shops.

Car ParkThe Prague Congress Centre has a garage with zones for short-term and long-term parking. The rates are approximately 2 EUR per hour or 18 EUR per 24 hours

Climate and DressGeographically speaking, the Czech Republic is situated in a temperate zone, and there are four seasons of approximately all the same length. Winters are relatively mild and summers are generally not too hot. In June, the weather in Prague is usually quite pleasant and mild with temperatures around 15-20°C. However, evenings can be somewhat chilly.

CustomsWhen bringing goods into the Czech Republic there are limits set on certain commodities. If a certain amount is exceeded, duty must be paid, and the importer is required to inform customs of the amount of the commodity he or she is bringing in to the country.

Credit CardsAll major credit cards are accepted in most hotels, international shops and more expensive restaurants. Many local shops and cheaper restaurants do not accept credit cards. If you have a choice of paying in cash or by credit card, cash is always preferred.

CurrencyThe official currency in the Czech Republic is CZK (Czech Crowns) of which 1 CZK is currently worth approximately EUR 0.04 (October 2010). Exchange of foreign currency is available at Prague International Airport and at most hotels, banks and exchange offices throughout the city. Please visit www.oanda.com for the latest currency rate.

Data ProtectionWe will keep your correspondence details on file. Please note that those details will be used

only in PharmSciFair related communication, for the purpose of marketing by official PharmSciFair partners (Sponsors and Exhibitors) and/or future events.

Please be informed that some events, such as Industry Sponsored Sessions, may require a separate invitation and communication on this will be made only to those delegates who have accepted to be contacted by these partners.

Disclaimer and Force MajeureThe Organising Committee and Congrex Sweden AB cannot accept liability for injuries or losses of whatever nature incurred by participants and/or accompanying guests, nor for loss of or damage to their luggage and/or personal belongings. Neither the PharmSciFair nor its committees, representatives or agents, shall be held liable by any person as a result of the cancellation of the 2011 PharmSciFair or of any of the arrangements, programs or plans connected therewith, or for any injury, damage or inconvenience which may be suffered by any person while travelling to or from, or during such person's presence in The Check Republic in connection with this conference. Participants and accompanying guest are advised to purchase their own insurance against any such occurrences.

In case of force majeure, PharmSciFair and its Organisers have the right to alter or cancel the conference without prior notice, however a notice of the occurrence shall be given by the Organisers as soon as reasonably possible. Force majeure shall mean any circumstance beyond the reasonable control of PharmSciFair and its Organisers which prevents or impedes the holding of the conference, including, but not limited to, government action, war or hostilities, riot or civil commotion, plague or other epidemic such as SARS, bird flu, etc, earthquake, flood, hurricane, cyclone, fire or other natural physical disaster, explosion, accident or breakdown, strike, lack of the usual means of transportation or terrorism. PharmSciFair and its Organisers

19

shall not be liable for any direct or indirect, incidental or consequential damages, losses, expenditures or any other inconveniences or costs caused by such modification or cancellation of the conference. Furthermore, registration fees will not be reimbursed.

ElectricityElectricity AC in the Czech Republic is 230 volts. Neither current nor plug sizes are the same around the world.

Map of the City of PraguePlease visit www.pharmscifair.org and/or the on-line registration link, or alternatively www.prague-info.cz for a map of the City of Prague.

On-site Registration and SecretariatOn-site Registration will commence at the Prague Congress Centre on Monday afternoon, June 13, 2011 at 17:00. The PharmSciFair Welcome Reception will start at 18:30 in the Exhibition area. The Welcome Reception and the On-site Registration will stay open until 20:30 for the purpose of making delegates feel welcome and inspired

for the PharmSciFair. The On-site Secretariat will be open all days during the Event.

Passport, Visa and Invitation LetterParticipants are advised to make their own arrangements with respect to entering the Czech Republic. All delegates are requested to investigate what necessary documents and/or applications are required when travelling to the Czech Republic.

Individuals requiring an official letter of invitation in order to obtain a visa and authorisation to attend the meeting should contact Congrex at [email protected]

Tourist InformationThanks to its location at the crossroads of various cultures, the Czech Republic has countless cultural and historical points of interest. Prague, its capital, is the most valuable historical city reserve. In 1992, the historical core of the city covering 866 hectares was listed in the UNESCO World Cultural and Natural Heritage Register.

Please visit www.prague-info.cz for useful and interesting information.

Do not miss this great opportunity to experience 2011 PharmSciFair within this magnificent city full of history!

TimeCzech Republic is located in the Western European time zone.April to September: Greenwich GMT+2 and October to March: Greenwich GMT +1.

TippingWhile tips are gratefully received by people in the tourist industry in Prague, tipping is fairly relaxed. As a general rule, if you are happy with the service you have received, a tip of 5%-10% is appropriate.

Travel InsuranceA travel insurance policy to cover theft, loss and medical problems is recommended. The Organisers shall not be held liable for illness, accidents or thefts suffered by delegates or Accompanying Guests during the meeting or their stay in the Czech Republic before or after the conference.

Registration, accommodation, abstract handling, exhibition and sponsorship management and organisationCongrex Sweden ABPO Box 5619, SE-114 86 Stockholm, SwedenTel +46 8 4596600. Fax +46 8 [email protected] (general questions, exhibition and sponsorship)[email protected] (registration and accommodation queries)[email protected] (abstract and scientific programme questions)www.congrex.com

Overall scientific programme and scientific secretariatEUFEPS OfficeVeddesta Business CenterSE-175 72 Järfälla (Stockholm), SwedenTel +46 8 50582040Fax +46 8 [email protected]

Prague Congress Centre5.kvetna 65140 21 Prague 4CZ-Czech RepublicTel +420 261 171111Fax +420 261 172062 www.kcp.cz

www.pharmscifair.org

2nd

Ann

ounc

emen

t -

Janu

ary

201

1, C

amill

a B

oqui

st/L

ådan

& C

o A

B

Contacts and Venue Information

PharmSciFair Scientific Programme Providing Partner Organisations 1st, 2nd or 3rd PharmSciFair Scientific Programme Providing Partners

• European Federation for Pharmaceutical Sciences (EUFEPS)• Academy of Pharmaceutical Sciences in United Kingdom (APS)• Association de Pharmacie Galénique Industrielle (APGI)• Association Française des Affaires Réglementaires (AFAR)• Associazione Docenti e Ricercatori Italiani di Tecnologie e Legislazione Farmaceutiche (ADRITELF)• Associazione Farmaceutici Industria (AFI)• Austrian Pharmaceutical Society (ÖPhG)• Belgian Society of Pharmaceutical Sciences (BSPS)• Consorzio Interuniversitario Nazionale di Tecnologie Farmaceutiche Innovative (TEFARCO Innova)• Deutsche Pharmazeutische Gesellschaft (DPhG)• Dutch Top Institute Pharma (TI Pharma)• EUFEPS Network Bioavailability and Biopharmaceutics• EUFEPS Network Environment and Pharmaceuticals• EUFEPS Network Food and Drug Synergy• EUFEPS Network NanoMedicine• EUFEPS Network PharmacoGenetics and PharmacoGenomics• EUFEPS Network QbD and PAT Sciences• EUFEPS Network Safety Sciences• European Association of Faculties of Pharmacy (EAFP)• European Association of Nuclear Medicine (EANM)• European Association of Pharma Biotechnology (EAPB)• European Centre for the Evaluation of Alternative Methods (ECVAM)• European Directorate for the Quality of Medicines & HealthCare (EDQM)• European Federation for Medicinal Chemistry (EFMC) • European Journal of Pharmaceutical Sciences (EJPS)• European Medicines Agency (EMEA)• European Pharmaceutical Students’ Association (EPSA)

• European Pharmacopoeia (PhEur)• European Society of Clinical Pharmacy (ESCP)• European University Consortium for Advanced Pharmaceutical Education and Research (ULLA)• Finnish Pharmaceutical Society (FPhS)• Hungarian Society for Pharmaceutical Sciences (HSPS)• Innovative Medicines Initiative Joint Undertaking (IMI JU)• Institute for Health and Consumer Protection (IHCP)• International Association for Pharmaceutical Technology (APV)• International Pharmaceutical Excipients Council Europe (IPEC Europe)• International Pharmaceutical Federation (FIP)• International Society for the Study of Xenobiotics (ISSX)• International Society of Pharmaceutical Engineering Europe (ISPE Europe)• Italian Society for Pharmaceutical Sciences (SISF)• Netherlands Society for Pharmaceutical Sciences (NVFW)• Pharmaceutical Society of Denmark (SPD)• Slovenian Pharmaceutical Society (SFD)• Society for Medicinal Plant and Natural Product Research (GA)• Société de Chimie Thérapeutique in France (SCT)• Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG)• Swedish Academy of Pharmaceutical Sciences (SAPS)• Swedish Proteomics Society (SPS)• The Society of Radiopharmaceutical Sciences (SRS)• Turkish Pharmaceutical Technology Scientists’ Association (TÜFTAD)• Turkish Pharmacological Society (TPS)• University of Helsinki (HY)

Pharmaceutical Sciences for the Future of Medicines · Sciences Fair and Exhibition. This event for...

Documents

Transcript of Pharmaceutical Sciences for the Future of Medicines · Sciences Fair and Exhibition. This event for...